Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, outlines the latest advances in the management of multiple myeloma (MM), including newly diagnosed and relapsed/refractory patients. Additionally, Dr Zamagni shares her perspective on the future of MM therapy and where the field is expected to move. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).